William John Sibold - 09 Sep 2024 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role
President and CEO, Director
Signature
/s/ Mardi Dier**
Issuer symbol
MDGL
Transactions as of
09 Sep 2024
Net transactions value
-$1,551,490
Form type
4
Filing time
11 Sep 2024, 21:51:22 UTC
Previous filing
25 Jan 2024
Next filing
27 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDGL Common Stock Sale $1,551,490 -6,363 -10% $243.83 55,887 09 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Remarks:

** As attorney-in-fact for Reporting Person